Project 2: The impact of biobehavioral factors and aspirin on ovarian cancer biology

项目2：生物行为因素和阿司匹林对卵巢癌生物学的影响

• 批准号: 10762082
• 负责人: Lauren Cole Peres
• 金额: $ 20.66万
• 依托单位: H. LEE MOFFITT CANCER CTR & RES INST
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-24 至 2026-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10762082
• 关键词: ADRB2 gene; Adrenergic Receptor; Anxiety; Aspirin; Attenuated; Biological; Biological Assay; Black race; Cancer Biology; Cancer Center; Carcinoma; Case Series; Case/Control Studies; Chronic stress; Clinical; Data; Development; Diagnosis; Disease; Distress; Dose; Emotional; Enzyme-Linked Immunosorbent Assay; Epithelial ovarian cancer; Ethnic Origin; Evaluation; Future; Gene Expression; Genes; Goals; Health Sciences; Hispanic; Hormones; Hospitals; Human; Immune; Immune response; Immunity; Immunosuppression; Infiltration; Inflammation; Inflammatory; Inflammatory Response; Intervention; Latina; Lead; Malignant Neoplasms; Malignant neoplasm of ovary; Measures; Mediating; Mental Depression; Mus; Norepinephrine; Not Hispanic or Latino; Outcome; Pathway interactions; Patient Self-Report; Patients; Pharmacotherapy; Population Heterogeneity; Population Intervention; Population Study; Prevention strategy; Process; Prospective cohort; Prostaglandins; Puerto Rico; Race; Reporting; Research; Research Project Grants; Resources; Risk; Role; Sampling; Science; Serous; Services; Stress; Sympathetic Nervous System; Time; Tissues; Tumor Immunity; Tumor Tissue; Tumor-associated macrophages; Universities; Up-Regulation; Woman; Work; adaptive immunity; biobank; biobehavior; bisphosphonate; cancer risk; cancer survival; carcinogenicity; education research; epidemiologic data; ethnic disparity; ethnic diversity; exome; experience; high risk; immune function; improved; innovation; mouse model; novel; outreach; ovarian cancer prevention; ovarian neoplasm; pharmacologic; population based; prevent; prospective; psychosocial; racial disparity; racial diversity; response; restraint stress; systemic inflammatory response; transcriptome sequencing; tumor; tumor growth; tumor microenvironment; tumor progression; tumorigenesis

ABSTRACT | FULL RESEARCH PROJECT 2 Growing evidence indicates that the biological response to chronic stress and subsequent distress can promote the progression of epithelial ovarian cancer via prolonged activation of the sympathetic nervous system and sustained norepinephrine release. Downstream consequences of norepinephrine exposure include increased prostaglandin-related inflammation and an immunosuppressive landscape. Conversely, increasing evidence supports the role of aspirin use in ovarian cancer prevention and survival. Yet, key questions remain about the underlying biological mechanism of action of chronic stress/distress and aspirin use (considering low and standard doses separately) and their interrelationship with ovarian cancer biology. Specifically, we propose to evaluate the hypothesis that distress enhances ovarian cancer progression by promoting inflammatory and immune processes and that aspirin abrogates these effects. Our innovative study uses unique population-based and experimental resources. Aim 1 will use data from four long-term prospective cohorts in diverse populations, a population-based case-control study, a hospital case series that collected self-reported measures of chronic stress and distress (e.g., depression), and ovarian tumor tissue. Aim 1 will measure gene expression in bulk high grade serous tumor samples (to capture the full tumor microenvironment) using whole exome RNASeq. We hypothesize that distress is associated with the up- regulation of inflammation-related and immune suppression gene expression pathways that is normalized among aspirin users. We will also assess if the association of distress with ovarian cancer risk is attenuated among aspirin users. Notably, we are leveraging racially and ethnically diverse studies that have highly characterized ovarian cancer cases, allowing assessment of differences in association by race (Black, White) and ethnicity (Hispanic, non-Hispanic), as well as the examination of associations between distress- related gene expression profiles and clinical outcomes. Using an orthogonal and interactive approach, Aim 2 will use experimental ovarian cancer mouse models to characterize the progressive effect over time of daily restraint stress on tumor inflammation and immunity as well as ovarian tumor growth, using RNASeq and stress hormones measured via ELISA assays. We also will examine if aspirin (recapitulating equivalents of low and standard dose aspirin in humans) counteracts the effects of chronic stress on tumor progression and inflammatory and immune gene expression networks. This project will leverage the scientific services of several cores, including the Puerto Rico BioBank (PRBB) and the Quantitative Science Core (QSC), with substantial interaction with the Outreach Core, the Planning and Evaluation Core, and working with trainees in the Research Education Core. This innovative application will inform future work to develop novel immuno- preventive strategies, pharmacotherapies, and psychosocial interventions to prevent and treat invasive ovarian cancer in women who experience chronic stress and distress.

摘要|完整研究项目2 越来越多的证据表明，对慢性压力和随后的痛苦的生物反应， 通过延长交感神经的激活促进上皮性卵巢癌的进展 系统和持续的去甲肾上腺素释放。去甲肾上腺素暴露的下游后果 包括增加的胰头素相关的炎症和免疫抑制状况。相反地， 越来越多的证据支持阿司匹林在卵巢癌预防和生存中的作用。然而，关键 关于慢性压力/痛苦和阿司匹林作用的潜在生物学机制仍然存在疑问。 使用（分别考虑低剂量和标准剂量）及其与卵巢癌生物学的相互关系。 具体来说，我们建议通过以下方式评估痛苦会加速卵巢癌进展的假设 促进炎症和免疫过程，阿司匹林消除这些作用。我们的创新研究 使用独特的基于人口和实验的资源。Aim 1将使用四个长期的数据， 不同人群的前瞻性队列，一项基于人群的病例对照研究，一项医院病例系列， 收集慢性压力和痛苦的自我报告测量（例如，抑郁症）和卵巢肿瘤组织。 目的1将测量大量高级别浆液性肿瘤样本中的基因表达（以捕获完整的肿瘤 微环境），使用全外显子组RNASeq.我们假设痛苦与- 正常化的炎症相关和免疫抑制基因表达途径的调节 阿司匹林使用者我们还将评估是否与卵巢癌风险的痛苦是减弱关联 在阿司匹林使用者中。值得注意的是，我们正在利用种族和民族多样化的研究， 特征性的卵巢癌病例，允许通过种族评估相关性的差异（Black， 白色）和种族（西班牙裔，非西班牙裔），以及痛苦之间的关联检查- 相关基因表达谱和临床结果。采用正交和交互式方法，目标2 将使用实验性卵巢癌小鼠模型来表征随着时间的推移， 抑制肿瘤炎症和免疫以及卵巢肿瘤生长的压力，使用RNASeq和 通过ELISA测定来测量应激激素。我们还将检查阿司匹林（概括相当于 低剂量和标准剂量阿司匹林）抵消慢性应激对肿瘤进展的影响， 炎症和免疫基因表达网络。该项目将利用 几个核心，包括波多黎各生物银行（PRBB）和定量科学核心（QSC）， 与外联核心、规划和评价核心进行实质性互动，并与 研究教育的核心。这一创新应用将为未来开发新型免疫抑制剂提供信息。 预防策略、药物治疗和心理社会干预，以预防和治疗侵入性 卵巢癌的女性谁经历慢性压力和痛苦。